RT Journal Article
SR Electronic
T1 The incubation period for monkeypox cases confirmed in the Netherlands, May 2022
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.09.22276068
DO 10.1101/2022.06.09.22276068
A1 Miura, Fuminari
A1 van Ewijk, Catharina Else
A1 Backer, Jantien A.
A1 Xiridou, Maria
A1 Franz, Eelco
A1 de Coul, Eline Op
A1 Brandwagt, Diederik
A1 van Cleef, Brigitte
A1 van Rijckevorsel, Gini
A1 Swaan, Corien
A1 van den Hof, Susan
A1 Wallinga, Jacco
YR 2022
UL http://medrxiv.org/content/early/2022/06/13/2022.06.09.22276068.abstract
AB In May 2022 outbreaks of monkeypox have been reported in countries where the monkeypox virus is not endemic. We estimate the incubation period for monkeypox, using the reported time of exposure and symptom onset for 18 confirmed cases detected in the Netherlands up to 31st May 2022. The mean incubation period was 8.5 days, ranging from 4.2 to 17.3 days (5th to 95th percentiles). These findings underpin 21 days for monitoring or quarantining of case contacts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was financed by the Netherlands Ministry of Health, Welfare and Sport. FM acknowledges funding from Japan Society for the Promotion of Science (JSPS KAKENHI, Grant Number 20J00793).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Centre for Clinical Expertise (CCE) at the RIVM (Netherlands Institute for Public Health and the Environment) is the official body in our Institute, responsible for advice and oversight on human-related research. The CCE assessed the research presented in this paper, and verified whether the work complies with the specific conditions as stated in the law for medical research involving human subjects (WMO). The CCE is of the opinion that the research does not fulfill one or both of these conditions and therefore concludes that it is exempted for further approval by the ethical research committee.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymized data and all codes used for analysis and visualization are available on Github (https://github.com/fmiura/MpxInc_2022). https://github.com/fmiura/MpxInc_2022